SPONSOR

University of Pennsylvania

Total Trials

Recruiting

Phases

EARLY_Phase 1, Phase 1, Phase 2, Phase 4, Phase 1, Phase 2

Conditions studied: Hypertrophic Cardiomyopathy Without Obstruction Genetic Predisposition Paraganglioma Pheochromocytoma ALS Parkinson Disease Polyneuropathies Frontotemporal Dementia Alzheimer Disease Cardiomyopathy Non-ischemic

University of Pennsylvania is a clinical research sponsor with 30 registered studies on ClinicalTrials.gov, of which 30 are actively recruiting participants. Research covers conditions including Hypertrophic Cardiomyopathy Without Obstruction, Genetic Predisposition, Paraganglioma, Pheochromocytoma.

The trial portfolio spans EARLY_Phase 1, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Pennsylvania

How many clinical trials has University of Pennsylvania sponsored?

ClinicalMetric currently tracks 30 clinical trials sponsored by University of Pennsylvania, of which 30 are actively recruiting participants. These trials cover conditions including Hypertrophic Cardiomyopathy Without Obstruction, Genetic Predisposition, Paraganglioma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University of Pennsylvania research focus on?

University of Pennsylvania clinical trials span Hypertrophic Cardiomyopathy Without Obstruction, Genetic Predisposition, Paraganglioma, Pheochromocytoma, ALS, and additional conditions. The research pipeline includes EARLY_Phase 1, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University of Pennsylvania clinical trial?

To participate in a University of Pennsylvania trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Pennsylvania trials with current recruitment status updated daily.

University of Pennsylvania

Frequently Asked Questions — University of Pennsylvania

Clinical Trials by University of Pennsylvania

Sodium Glucose Co-transporter (SGLT) Inhibitors in Nonobstructive Hypertrophic Cardiomyopathy

Using the EHR to Advance Genomic Medicine Across a Diverse Health System

Testing a Measurement Feedback App to Improve Data Quality, Supervision & Outcomes in Behavioral Health

Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement

One-Time DNA Study for Vasculitis

Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A

Intervention to Improve Parent Communication About Sexuality

Different Approaches for CART-EGFR-IL13Ra2 Dosing in Recurrent GBM

Conversational AI Platform for Early Pregnancy Care City-wide Recruitment: A Feasibility Study

International Registry for Patients With Castleman Disease

Integrating Brain, Neurocognitive, and Computational Tools in OUD

Cervical Ripening as an Outpatient Method Using the Foley (COMFORT)

Suicide Assessment and Feasible Evidence-based Treatments for Youth Living With HIV in Lilongwe

Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus

Longitudinal Study for Relapsing Polychondritis

Healing at Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression

Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients

CW2IP2: Imaging and Diagnostic Assessments

Food Genetics Behavior Study

TmCD19-IL18 in CD19+ Cancers

Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation

CD45BE-HSPC + CART-45 Cells

Study of Immune Responses to Influenza Vaccination

Philly CEAL- DECIDE+ Adaptation

Feasibility of Semaglutide in Advanced Lung Disease

Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use

Supraglottic Airway for Resuscitation in Preemies

Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503

CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy

Randomized Clinical Trial of TUNE In 3.0: A Social/Emotional Program for Adults With Autism Spectrum Disorder